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of serum BMPs.
RESULTS Subjects with Agatston score  400 (n¼254) had higher
serum levels of BMP-2 (116.3 12.5pg/ml vs. 87.8 10.7pg/ml,
p<0.001), BMP-4 (91.2 9.7pg/ml vs. 73.28.7pg/ml, p¼0.017) and
BMP-7 (91.2 8.3pg/ml vs. 51.3 5.9pg/ml, p<0.001) than those
with Agatston score < 400 (n¼319). Agatston scores were posi-
tively correlated with the serum levels of BMP-2 (r¼0.624, p<0.001),
BMP-4 (r¼0.503, p<0.001) and BMP-7(r¼0.662, p<0.001). After
adjustment for other risk factors, multivariate logistic regres-
sion analysis considered that increased serum levels of BMP-2
[OR:1.646(1.125,3.073), p<0.001], BMP-4 [OR:1.243(1.033,3.135),
p¼0.023] and BMP-7 [OR:2.085(1.376,3.598), p<0.001] were indepen-
dent predictors for the progression of CAC.
CONCLUSIONS Serum BMP-2, BMP-4 and BMP-7 can predict the CAC
in the elderly.
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OBJECTIVES To uncover the value of Soluble urokinase-type plas-
minogen activator receptor (su-PAR) in predicting major adverse
cardiovascular events (MACE) among patients with acute coronary
syndrome (ACS) undergoing percutaneous coronary intervention
(PCI).
METHODS A total of 103 patients with ACS undergoing PCI in Cardi-
ology Department of SUN Yat-sen University The Third Afﬁliated
Hospital between June 2005 to August 2006 were enrolled. In all these
patients, we measured the lever of su-PAR in plasma with a solid
phaseenzyme-linked immuneosorbent assay (ELISA) when the cases
were brought into this study and two weeks after they were brought
into this study. We divided all the cases into three groups according to
the u-PAR. The end points were all-cause mortality and fatal or
nonfatal recurrent myocardial infarction (MI).
RESULTS During a median follow-up period of 7 years, 13 deaths and 3
fatal and 11 nonfatal recurrent MIs occurred. MACE rates of low, in-
termediate, and high tertiles according to the su-PAR were 12.1%,
20.0% and 31.4%, respectively. Both univariate analysis and multi-
variate analysis showed that the su-PAR was the independent pre-
dictor of MACE (HR¼2.28, 95%CI (1.41, 3.39), P¼0.002; HR¼2.16, 95%
CI (1.32, 3.38), P¼0.005).
CONCLUSIONS Urokinase-type plasminogen activator receptor could
be a independent risk predictor of major adverse cardiovascular
events among patients with acute coronary syndrome undergoing
percutaneous coronary intervention.
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OBJECTIVES To ﬁnd the relationship between different levels of
glycosylated hemoglobin and severity of coronary artery lesions in
patients with coronary heart disease and type 2 diabetes mellitus.
METHODS We collected the data of 184 patients with coronary heart
disease and type 2 diabetes mellitus. Then the patients were divided
into three groups based on glycosylated hemoglobin levels including
group A (n¼70, HbA1C7.0%), group B (n¼37, 7.0%<HbA1C<8.0%),
and group C (n¼77, HbA1C8.0%). Gensini score was used to assess
the severity of coronary lesions by coronary angiography. All statis-
tical tests were operated with program SPSS13.0 and P<0.05 was
considered statistically signiﬁcant.
RESULTS (1) The incidence of left main lesions was 7.1%, 2.7%, and
10.4% in group A, group B, group C, respectively. The prevalence of
diffuse lesions in each group was 32.9%, 24.3%, and 26.0%, respec-
tively. The prevalence of complete occlusive lesions in each groupwas 28.6%, 27.0%, and 27.3%, respectively. There were no sig-
niﬁcant differences in the left main lesions, diffuse lesions, and
complete occlusive lesions between three groups (P>0.05). (2) The
median of Gensini score of threegroups was 57.75, 56.00, 46.00,
respectively. By square root transformation, all the ratios of the
Gensini score are normal distribution, One-way ANOVA was used as
appropriate to compare means among different groups, and the re-
sults show no signiﬁcant differences between the three groups
(P>0.05).
CONCLUSIONS Among patients with coronary heart disease and type
2 diabetes mellitus, there was no signiﬁcant correlation between
glycosylated hemoglobin and severity of coronary artery lesions.
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OBJECTIVES To explore the correlation between clopidogrel low
response and CYP2C19 gene polymorphism in coronary artery disease
(CAD) patients after percutaneous coronary intervention (PCI ).
METHODS A total of 200 patients with CAD after PCI are admitted to
our hospital from October 2013 to October 2014 in this study, and
treated with dual antiplatelet drugs, aspirin and clopidogrel. The
clopidogrel response is judged by depending on the ADP-induced
platelet inhibition rate tested by thromboelastogram. In this study the
ADP-induced platelet inhibition rate less than 30% is deﬁned as clo-
pidogrel low response and the gene chip detection technology is used
to detect the genotype of CYP2C19 to further explore the correlation
between clopidogrel low response and CYP2C19 gene polymorphism
in CAD patients after PCI.
RESULTS In these 200 patients, the ADP-induced platelet inhibition
rate is signiﬁcantly statistical difference between patients carrying
CYP2C19*1/*1 and CYP2C19*1/*2, CYP2C19*1/*1 and CYP2C19*2/*2. The
total occurrence of clopidogrel low response is 39.5%(79 patients).
There is signiﬁcant difference between clopidogrel low response and
CYP2C19 genotyes, metabolizers, indicating that less patients with
extensive metabolizer (CYP2C19*1/*1) in the clopidogrel response
group, more patients with intermediate or poor metabolizers in the
clopidogrel low response group.
CONCLUSIONS There is correlation between clopidogrel low response
and CYP2C19 gene polymorphism in patients with CAD, more carriers
with intermediate or poor metabolizers in the clopidogrel low
response group.
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Non-alcoholic fatty liver disease affects the relationship between
epicardium and coronary atherosclerotic heart disease
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OBJECTIVES To explore the relationship between the various parts of
the visceral fat (VF) and coronary atherosclerotic heart disease (CAD),
and to ﬁnd whether Non-alcoholic fatty liver disease (NAFLD) affects
the correlation between VF and CAD. The results can provide a new
reference index for the prevention, prediction, treatment and reha-
bilitation of CAD.
METHODS This study selected 339 patients, We used ultrasonography
to measure the thickness of various parts VF and NAFLD. According to
the results of coronary angiography, we determined the patients with
CAD and used Gensini value to evaluate the extent of lesion. Firstly,
according to the results of coronary angiography, the patients were
divided into CAD group and non CAD group to determine whether the
VF, NAFLD are the independent risk factors for CAD. Secondly, ac-
cording to Gensini value, the patients were divided into three groups
to investigate whether there is a relationship between VF and the
severity of CAD. Finally, the CAD patients were divided into NAFLD
group and non NAFDL group to determine the relationship between
NAFLD and VF, and the inﬂuence of NAFLD on the relationship be-
tween VF and CAD.
RESULTS Using the single factor analysis, we found that epicardium,
NAFLD, smoking, high blood pressure, HDL-C, LDL-C, TG in CAD
group were signiﬁcantly higher than those in non-CAD group
(P<0.05). There was no signiﬁcant difference between the two groups
